Human Tip60 (NuA4) Complex and Cancer by Hiroshi Y. Yamada
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Human Tip60 (NuA4) Complex and Cancer 
Hiroshi Y. Yamada 
University of Oklahoma Health Sciences Center (OUHSC), 
 USA 
1. Introduction  
Recent publications implicate human Tip60 (NuA4) complex in colorectal and other 
cancers. Our lab and others discovered deregulations in the components of human Tip60 
(NuA4) complex in advanced colon cancers, and the functional significance and the 
potential as a therapeutic target, has been investigated. Human Tip60 (NuA4) complex 
likely represents a fusion form of yeast NuA4 and SWR1 complexes, and the functions 
seem to be evolutionarily preserved. This notion has greatly contributed in understanding 
functions of human Tip60 (NuA4) complex. The Tip60 (NuA4) complex is a multiprotein 
complex with at least 16 subunits. It is thought to function in at least  two ways; (a) as a 
chromatin remodeling factor, it controls chromatin structure and transcription through its 
Histone Acetyl Transferase (HAT) activity, and (b) it controls activities of other non-
histone proteins, such as metabolic enzymes, through protein acetylation. Through the 
enzymatic activity and other interactions, Tip60 (NuA4) complex is involved in wide 
variety of cellular functions, including transcriptional activation, DNA repair, cell cycle 
progression, chromosome stability, stem cell maintenance and differentiation, and cell 
migration and invasion. This review will discuss functions of Tip60 (NuA4) complex, 
consequences of the defect in the subunit, its connection to human cancer, and its 
potential as a therapeutic target in clinic.  
2. A chromatin remodeling factor with Histone Acetyl Transferase (HAT) 
activity, Tip60 (NuA4) complex  
Readout of genomic information is regulated through multiple mechanisms. A major part 
of the regulatory role is played by chromatin remodeling factors; enzyme complexes that 
modify DNA or chromatin proteins. The modifications change local chromatin structure, 
thus change accessibility of transcription factors and availability of genomic information 
(Kouzarides 2007). In the case of Histones and major chromatin proteins, protein 
modifications occur in a variety of ways, including phosphorylation, acetylation, 
methylation, ubiquitylation, and ADP-ribosylation. These different types of modifications 
may functionally influence each other, creating possibilities of multiple layers of 
regulations, which have been referred as the “Histone code”. Although the possibility has 
been pointed out, the multiple layers of regulations (the “Histone code”) have not fully 
been deciphered yet.   
Among the modifications, acetylation has a defined role: To change surface charge 
distribution of the target protein and change accessibility to DNA and/or to other proteins. 
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The histones are acetylated and deacetylated on lysine residues in the N-terminal tail. These 
acetylation/deacetylation reactions are catalyzed by two groups of enzymes, Histone Acetyl 
Transferase (HAT) and Histone DeACetylase (HDAC), respectively. Histones are not the 
only target for these enzymes. HATs and HDACs can acetylate/deacetylate non-histone 
proteins as well.   
In this review, we will focus on a human multisubunit and multifunctional HAT complex, 
Tip60 (NuA4) (Nucleosomal Acetyltransferase of H4) complex. We will describe the 
complex and known functions from the standpoint of each subunit and discuss new insights 
relevant to cancer, especially in colon cancer. We will also discuss the possibility of targeting 
Tip60 (NuA4) subunits for therapeutic purposes.  
3. Human Tip60 (NuA4) complex; Its components and functions  
Human Tip60 (NuA4) complex is a multiprotein complex with at least 16 subunits, and it 
has HAT activity (Cai et al., 2003, Doyon et al., 2004). The subunit composition suggests that 
Human Tip60 (NuA4) complex is a fusion form of two yeast HAT complexes, NuA4 and 
SWR (Allard et al, 1999) (Table 1). As seen in Table1, these two yeast HAT complexes share 
four components (Eaf2, Arp4, Act1 and Yaf9), together they correspond to all human 
subunits. Supporting the fusion theory, the expression of a chimeric Eaf1-Swr1 protein 
provides a scaffold for the complex assembly and recreates a single human-like complex in 
yeast cells (Auger et al, 2008).   
Historically speaking, yeast has been a superior model system to investigate functions of 
molecular and cellular machineries with its genetical tractability, its ease of experimental 
manipulations, feasibility for biochemistry and its short life cycle and time span for 
experiments. Several cellular functions of NuA4 and SWR complex were identified directly 
with yeast studies and later confirmed in human cultured cells. The known acetylation 
targets of yeast NuA4 in vivo are histone H4 (Mitchell et al., 2008) and the histone H2A 
variant Htz1 (Babiarz et al., 2006, Keogh et al., 2006, Mizuguchi et al., 2004). Yeast NuA4 
complex also targets non-histone proteins, which are equally important to evaluate cellular 
functions of NuA4 complex. With yeast protein array, Lin et al. (2009) screened the target 
proteins. Among 5800 proteins screened for in vitro acetylation with NuA4 complex, 91 
candidates were identified, 20 were selected for validation, and 13 were validated. The 
functions of validated proteins encompass metabolism, transcription, cell cycle, RNA 
processing, and stress response. The authors focused on Pck1, a key metabolic enzyme that 
regulates gluconeogenesis, and showed that Pck1 activity and glucose secretion is regulated 
through NuA4-mediated acetylation in yeast and in human hepatocellular carcinoma cells 
HepG2. Thus NuA4 is implicated in metabolism and energy generation through its non-
histone targets.  
The human TIP60 complex has at least three interrelated enzymatic activities: histone 
H4/H2A acetyltransferase, ATP-dependent H2AZ-H2B histone dimer exchange, and DNA 
helicase (Auger et al., 2008). Only a limited number of non-histone targets, including human 
Pck1, has been identified so far (Liu et al., 2009).  
Knockdown and/or mutational studies have been performed to identify functions of the 
subunits of human Tip60 (NuA4) complex. The studies implicate following biological events 
to Tip60 (NuA4) complex, directly or indirectly.  
www.intechopen.com
 
Human Tip60 (NuA4) Complex and Cancer 
 
219 
- DNA repair 
- Transcriptional regulation 
- Chromatin structure alteration 
- Interaction and/or regulation with factors relevant to tumorigenesis (e.g. c-myc, E1A, 
E2F1, p53, STAT3, NF-kappaB) 
- Cell migration and invasion 
- Mitosis 
- Genomic instability 
- Stem cell maintenance and differentiation  
In addition, RNAi-based screening with nematode C. elegans implicated Tip60 (NuA4) 
complex in attenuation of ras-signaling involving development of vulva in the model. The C. 
elegans MLL (Mixed Lineage Leukaemia (MLL)) complex-like complex cooperates with the 
TIP60 (NuA4) complex to regulate the expression of a novel ras-signaling attenuator, AJM-1 
(Fischer et al., 2010).  
4. Functions of each subunit  
In the following section we will discuss each of the subunits.  
4.1 TRRAP/Tra1/*  
(human protein/yeast protein in NuA4 complex/ yeast protein in Swr complex. Asterisk * 
if not applicable)   
Human TRRAP (transformation/transcription domain-associated protein) has a FATC 
(FRAP, ATM, TRRAP C-terminal) domain and a kinase domain, and belongs to ATM/PI3K 
family. However, TRRAP does not appear to possess kinase activity, because the kinase 
domain in TRRAP lacks the conserved amino acids required for ATP binding and catalytic 
activity for phosphate transfer. For that reason, it is speculated that TRRAP has evolved as a 
specialized PIKK member to serve as an adaptor/scaffold for protein–protein interaction 
and multiprotein assemblies or as a platform for recruitment of different regulatory factors 
and complexes to chromatin (Murr et al 2007). The FATC domain in the C-terminus likely 
affects the protein stability in an oxidation/redox-dependent manner (Dames et al., 2005).  
TRRAP is a common component of many HAT complexes (e.g. SAGA, PCAF and Tip60 
(NuA4) complex). As such, targeting TRRAP will influence a broader range of biological 
events and pathways than targeting more specialized components in Tip60 (NuA4) complex. 
TRRAP is one of the frequently mutated genes in melanoma. TRRAP harbored a recurrent 
mutation that clustered in one position (p. Ser722Phe) in 6 out of 167 affected individuals 
(∼4%), although the effects of the mutation on the protein function is unclear (Wei et al.,  
2011). Expression profiling revealed that TRRAP is frequently both amplified and 
overexpressed in Pancreatic Ductal AdenoCarcinoma (PDAC), and the overexpression is 
associated with poor prognosis (Bashyam et al., 2005, Loukopoulos et al,2007). In brain 
tumor-initiating cell, knockdown of TRRAP significantly increased differentiation and 
decreased cell cycle progression, leading to overall inhibition of tumor formation. The result 
indicates a critical role for TRRAP in maintaining a tumorigenic, stem cell-like state 
(Wurdak et al., 2010). TRRAP is shown to regulate a major player in colon cancer,  
beta-catenin. TRRAP interacts with Skp1/SCF and mediates its recruitment to beta-catenin  
target promoter in chromatin. TRRAP deletion leads to a reduced level of beta-catenin  
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Table 1. Subunits of Human Tip60 (NuA4); (columns from left) subunits of the yeast 
counterpart complexes NuA4 and SWR1; notable protein domains; yeast mutant 
phenotypes that implicate functions; inhibition in cultured cells and mice; and information 
relevant to cancer. ND: Not Determined. The order listed is following the size of the protein. 
Larger subunit is shown on top. 
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ubiquitination, lower degradation rate and accumulation of beta-catenin protein. 
Furthermore, recruitment of Skp1 to chromatin and ubiquitination of chromatin-bound 
beta-catenin are abolished upon TRRAP knock-down, leading to an abnormal retention of  
beta-catenin at the chromatin and concomitant hyperactivation of the canonical Wnt 
pathway (Finkbeiner et al., 2008). TRRAP is also involved in DNA damage repair. TRRAP 
depletion impairs both DNA-damage-induced histone H4 hyperacetylation and 
accumulation of repair molecules at sites of Double Strand Breaks (DSBs), resulting in 
defective homologous recombination (HR) repair, albeit with the presence of a functional 
ATM-dependent DNA-damage signaling cascade (Murr et al., 2006). TRRAP regulates 
expressions of many cancer-relevant genes, including mitotic checkpoint proteins Mad1 and 
Mad2 (Li et al., 2004) and mdm2 (Ard et al., 2002). 
Consistent with the loss of mitotic checkpoint proteins essential for cellular survival, null 
mutation of Trrap (mouse homolog of human TRRAP) results in peri-implantation lethality 
due to a blocked proliferation of blastocysts. Loss of Trrap blocks cell proliferation because 
of an aberrant mitotic exit accompanied by cytokinesis failure and endoreduplication. Trrap-
deficient cells failed to sustain mitotic arrest despite chromosome missegregation and 
disrupted spindles, and display compromised cdk1 activity. Thus, Trrap is essential for 
early development and required for the mitotic checkpoint, presumably through expression 
control of mad1 and mad2, and normal cell cycle progression (Herceg et al., 2001).   
In yeast, deletion of TRRAP homolog Tra1 is also lethal. Tra1 is identified as a component of 
multiple yeast transcription regulator complexes, Ada-Spt, SAGA and NuA4 (Saleh et al., 
1998; Grant et al., 1998; Allard et al., 1999). Tra1 directly interacts with the acidic 
transcriptional activators Gcn4, Hap4, and Gal4 (Brown et al., 2001). Tra1 is required for 
both the acetylation of Histone H4 surrounding the promoters and the transcription of Gcn4-
dependent genes, suggesting that Tra1 may mediate the recruitment of NuA4 to certain 
promoters.  
4.2 hDomino p400/Eaf1/Swr1  
hDomino (also known as p400, EP400, E1A binding protein p400) is a DEXH-box class of 
RNA-dependent ATPase subunit in Tip60 (NuA4) complex, and can destabilize histone-
DNA interactions in reconstituted nucleosomes in an ATP-dependent manner. hDomino 
also contains a highly conserved SANT (SWI3–ADA2–NcoR–TFIIIB) domain, a histone tail-
binding module (Boyer et al. 2004). The protein is related to yeast Swi2/Snf2 (SWItch 
2/Sucrose NonFermentable 2) and to Domino in fruit fly Drosophila. Drosophila Domino was 
isolated in search of immune system mutants devoid of circulating larval hemocytes from P-
element insertion-based mutant library. Because of the very striking lymph gland 
phenotype that results in mutant larvae with two black dots visible on the anterior half, the 
authors named the mutation domino (Braun et al., 1997). 
Through the Swi2/Snf2 domain, hDomino binds to adenovirus oncoprotein E1A. 
Mutational loss of E1A binding results in the loss of transformation, indicating that the 
binding plays a critical role in cellular transformation. hDomino also binds to c-myc with 
different protein components (Fuchs et al., 2001). In most human colorectal carcinoma, the 
ratio between Tip60 and p400 mRNAs is affected. Reversing the p400/Tip60 imbalance by 
Tip60 overexpression or the use of siRNAs resulted in increased apoptosis and decreased 
proliferation of colon-cancer-derived cells, suggesting that this ratio defect is important for 
cancer progression (Mattera et al., 2009).  
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In mice, p400 knockout results in embryonic lethality. Homozygous knockout mice died on 
embryonic day 11.5 (E11.5), and displayed an anemic appearance and slight deformity of the 
neural tube. Their results suggest that p400/mDomino plays a critical role in embryonic 
hematopoiesis by regulating the expression of developmentally essential genes such as those 
in the Hox gene cluster (Ueda et al., 2007). Tip60-p400 is necessary to maintain characteristic 
features of Embryonic Stem Cells (ESCs) (Fazzio et al., 2008). Through an RNAi screen in 
mouse ESCs of 1008 loci encoding chromatin protein, the authors identified 68 proteins that 
exhibit diverse phenotypes upon knockdown, including seven subunits of the Tip60-p400 
complex, Trrap, Tip60, p400, DMAP1, RuvBL1, RuvBL2 and GAS41. Phenotypic analyses 
revealed that p400 localization to the promoters of both silent and active genes is dependent 
upon histone H3 lysine 4 trimethylation (H3K4me3). The Tip60-p400 knockdown gene 
expression profile is enriched for developmental regulators and significantly overlaps with 
that of the transcription factor Nanog. Depletion of Nanog reduces p400 binding to target 
promoters without affecting H3K4me3 levels. Together, these data indicate that Tip60-p400 
integrates signals from Nanog and H3K4me3 to regulate gene expression in ESCs (Fazzio et 
al., 2008).  
Yeast p400 homolog Eaf1 (Esa1-associated Factor 1, VID21) is the only subunit exclusively 
found in the NuA4 complex in biochemical preparation. Eaf1 is the platform on which four 
different functional modules of the other subunits are assembled into the native complex 
(Auger et al., 2008). Although eaf1 deletion strain is viable, the cells show genome instability 
and high incidences of sporulation defects and aneuploidy. The mutant is also highly 
sensitive to DNA damage-inducing stress such as X-ray (Auger et al., 2008; Hughes et al., 
2000; Krogan et al., 2004).  
4.3 Brd8/*/Bdf1  
Human Brd8 was functionally identified as a Thyroid hormone receptor coactivator p120 
(Monden et al., 1997; Yuan et al., 1998). Later, its role as a transcriptional coactivator with 
RXR/PPAR-gamma was also reported, establishing the role as a nuclear receptor coactivator 
(Monden et al., 1999). Human Brd8 has one or two Bromodomain(s), depending on the 
isoform. The Bromodomain is a domain that can bind to acetylated lysine, typically 
observed in histones, suggesting its role in regulating protein-protein interactions in 
histone-directed chromatin remodeling and gene transcription. (Zeng and Zhou, 2002; 
Mujtaba et al., 2007).  
Brd8 was isolated through a HeLa cell-based expression cloning for genes that influence 
sensitivity to a microtubule inhibitor (Yamada and Gorbsky, 2006). Ectopic expression of 
Brd8 provides partial resistance to microtubule inhibitors and proteasome inhibitor, and 
knockdown sensitized cells to the drugs, suggesting Brd8 influences sensitivity to 
microtubule inhibitors and proteasome inhibitor (Yamada and Rao, 2008). Human Brd8 
protein is overexpressed in human metastatic colorectal cancer cell lines. Brd8 is also 
overexpressed in advanced colon adenocarcinoma in rats induced with Dextran sulfate and 
azoxymethane (an inflammatory colon cancer model system). SiRNA-mediated Brd8 
knockdown resulted in cell death in HCT116 and growth delay in DLD1, both are colorectal 
cancer cells (Yamada and Rao, 2008). With shRNA, an independent lab showed that 
inhibition of Brd8 resulted in growth inhibition (Yamaguchi et al., 2010), thus Brd8 is 
suspected to provide survival fitness and growth advantage. In our lab, transcriptome 
analysis showed little difference in the amount of Brd8 transcripts in colonic normal-looking 
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epithelial and cancer cells, yet the protein accumulates in cancer cells. The protein 
accumulation is enhanced with an addition of proteasome inhibitor in cultured human 
colon cancer cells, suggesting that a post translational, proteasome-dependent pathway is 
involved in the regulation (unpublished results).  
Yeast homolog Bdf1p (Bromo Domain Factor 1) contains two bromodomains and is thought 
to correspond to a missing piece of TFIID (Matangkasombut et al., 2000). Bdf1 deletion in 
yeast is viable, but affects general transcription including small nuclear RNA, sporulation, 
mitochondrial function and stress-induced cell death (Lygerou et al., 1994; Liu et al, 2009). 
Overexpression of Bdf1 can suppress phenotypes and defects of yaf9 (human GAS41 
homolog) deletion, indicating functional overlap between Bdf1 and Yaf9 (Bianchi et al., 
2004).  
4.4 Epc1/Epl1/* 
In Drosophila, EPC1 (Enhancer of PolyComb 1) mutation was isolated as a mutation that 
enhances the effect of homeotic proteins Polycomb. Although homozygotic mutations of 
Epc1 in Drosophila are lethal in the embryo, heterozygous mutations do not by themselves 
result in a zygotic homeotic phenotype (Stankunas et al, 1998). Epc1 protein is a chromatin 
protein with no known enzymatic activity by itself.  
EPC1 deregulation is observed in Adult T-cell leukemia/lymphoma (ATLL), a malignant 
tumor caused by latent human T-lymphotropic virus 1 (HTLV-1) infection. In acute-type 
ATLL, there is a common breakpoint cluster region at 10p11.2. The chromosomal 
breakpoints are localized within the enhancer of polycomb 1 (EPC1) gene locus (Nakahata et 
al., 2009).  
In mice development, Epc1 is involved in skeletal muscle differentiation. The expression of 
Epc1 mRNA is gradually decreased with aging from embryonic day 11.5 to postnatal week 
8. Epc1 is highly expressed in skeletal muscles and heart ventricle in week 8 mice (Kee et al., 
2007). Epc1 knockdown caused a decrease in the acetylation of histones associated with 
serum response element (SRE) of the skeletal alpha-actin promoter. The Epc1.SRF (Serum 
Response Factor) complex bound to the SRE, and the knockdown of Epc1 resulted in a 
decrease in SRF binding to the skeletal alpha-actin promoter. Epc1 recruited histone 
acetyltransferase activity, which was potentiated by cotransfection with p300 but abolished 
by siRNA-mediated p300 inhibition. Epc1 directly bound to p300 in myoblast cells. Epc1 
heterozygous mice showed distortion of skeletal alpha-actin, and the isolated myoblasts 
from the mice had impaired muscle differentiation. These results suggest that Epc1 is 
required for skeletal muscle differentiation by recruiting both SRF and p300 to the SRE of 
muscle-specific gene promoters (Kim et al., 2009).  
Deletion of Yeast homolog Epl1 (Enhancer of Polycomb Like 1) is inviable, causes cells to 
accumulate in G2/M and global loss of acetylated histones H4 and H2A (Boudreault et al., 
2003).  
4.5 Tip60/Esa1/* 
TIP60 in humans and Esa1 in yeast are the catalytic (acetyltransferase) subunit of the NuA4 
complex (Ikura et al., 2000; Smith et al., 1998) and play a central role in Tip60 (NuA4) 
complex function. MYC associates with TIP60 and recruits it to chromatin in vivo with four 
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The Tip60 histone acetyltransferase has been recently shown to be underexpressed in many 
human cancers from various origins (Lleonart et al., 2006; Gorrini et al., 2007). Moreover, in 
a model of tumor induction mice, it has been shown to function as a haploinsufficient tumor 
suppressor, providing a causal link between Tip60 underexpression and tumorigenesis 
(Gorrini et al., 2007). 
A down-regulation of the TIP60 gene was observed in 28 out of 46 (61%) specimens of 
primary gastric cancer (Sakuraba et al, 2011). As mentioned in p400, in colon cancer 
expression ratio of Tip60-p400 is altered, and it may be involved in tumor growth (Mattera 
et al., 2009).  
In yeast the catalytic subunit Esa1 is the only HAT protein essential for viability and is 
responsible for the bulk of histone H4 and H2A acetylation in vivo (Doyon and Cote, 2004). 
esa1 temperature sensitive (ts) mutants provoke a RAD9-dependent G2/M delay (Megee et 
al., 1995; Clarke et al., 1999). Yeast Esa1 mutation is inviable, and esa1 conditional mutation 
serve to dissolve whole complex (Allard et al., 1999).  
4.6 DMAP1/Eaf2/Eaf2  
Human DMAP1 and its yeast homolog Eaf2 contain a highly conserved SANT (SWI3–
ADA2–NcoR–TFIIIB) domain, a histone tail-binding module (Boyer et al. 2004). DMAP1 
(DNA methyltransferase (DNMT)-1 associated protein 1) is a subunit of the TIP60-p400 
complex that maintains embryonic stem (ES) cell pluripotency (Fazzio et al., 2008) and also a 
subunit of a complex containing the somatic form of DNA methyltransferase 1 (DNMT1s). 
The lack of DNMT1 in the purified TIP60-p400 complex indicates that DMAP1 interacts with 
DNMT1 in a distinct complex, thus DMAP1 functions in two distinct manner, as a Tip60 
(NuA4) complex and with DNMT1 (Cai et al. 2003, Doyon et al., 2004). The non-catalytic 
amino terminus of DNMT1 binds to HDAC2 and can mediate transcriptional repression 
(Rountree et al, 2000). DNMT1 is essential for epidermal progenitor cell function and 
replenishing the tissue (Sen et al., 2010).   
DMAP1 associated proteins (DNMT1,3A and 3B) were progressively upregulated in 
colorectal adenoma-carcinoma sequence (Schmidt et al., 2007). Since counteracting 
demethylase MBD2 amount remained unchanged, the authors suggested that epigenetic 
regulation in the adenoma-carcinoma sequence may be driven by increased methylating 
activity by DNMTs rather than suppressed demethylation.  
In mice, DMAP1 homozygous knockout resulted in lethality during preimplantation 
(Mohan et al., 2010). Reduction of the expression of DMAP1 caused a loss of characteristic 
ES cell morphology and activation of genes associated with cell differentiation (Fazzio et al., 
2008), and it is a likely cause of the embryonic lethal phenotype. Dmap1 knockdown in 
mouse embryonic fibroblasts (MEFs) lead to spontaneous double-strand breaks (DSBs), 
resulting in growth arrest because of p53-dependent cell cycle checkpoint activation 
(Negishi et al., 2009).  
Yeast homolog Eaf2 (also known as SWC4) is a shared component of NuA4 and SWR1 
complexes. Mutant yeasts are highly sensitive to DNA breaks induced by DNA-damaging 
agents, suggesting an essential role for these two proteins in DNA repair (Auger et al., 2008).  
4.7 Ing3/Yng2/* 
Human ING1 (Inhibitor of Growth 1) was identified as a tumor suppressor candidate, and 
subsequently the “Ing family” proteins (ING1-ING5) were investigated. Human Ing3 is  a 
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47kd protein with a C-terminal plant homeodomain (PHD)-finger motif, common in 
proteins involved in chromatin remodeling and is a sequence-specific histone recognition 
protein module (Gunduz et al., 2002; Nagashima et al., 2003; Sanchez and Zhou, 2011). 
p47ING3 activates p53-transactivated promoters, including promoters of p21/waf1 and bax. 
Thus p47ING3 modulates p53-mediated transcription, cell cycle control, and apoptosis. 
Later, ING family proteins are identified as components of chromatin remodeling 
complexes; ING1 in mSin3A HDAC, ING2 in an HDAC complex similar to ING1, ING3 in 
Tip60 (NuA4) HAT complex, ING4 in HBO1 HAT, and ING5 fractionates with two distinct 
complexes containing HBO1 or nucleosomal H3-specific MOZ/MORF HATs. (Doyon et al., 
2006).  
Consistent with the proposed function as a tumor suppressor, a decrease of ING3 expression 
or LOH are observed in tumors. Decreased or no expression of ING3 mRNA was observed 
in 50% of primary head and neck squamous cell carcinomas (HNSCC) as compared with 
that of matched normal samples. About 63% of tongue and larynx tumors showed the 
decrease, and a tendency of higher mortality was observed in cases with decreased ING3 
expression. It suggests that the ING3 gene functions as a tumor suppressor in a subset of 
HNSCC (Gunduz et al., 2002). Expression of ING3 is correlated with poor prognosis in 
HNSCC (Gunduz et al., 2008). Distorted ING3 expression has been found in several 
lymphoma-derived cell lines (Fadlelmola et al., 2008). Nuclear ING3 expression was 
reduced in melanomas in a Skp2-ubiquitin/proteasome pathway-dependent manner (Chen 
et al., 2010). This reduction was correlated with a poorer patient survival (Wang et al., 2007). 
Decreased ING3 expression is associated with melanoma progression and poor prognosis.  
The yeast Saccharomyces cerevisiae has three homologs of ING family proteins. Homolog of 
human ING3 is Yng2 (Loewith et al., 2000). Yng2 is a plant homeodomain (PHD)-finger 
protein and a NuA4 complex subunit. Deletion of YNG2 results in several phenotypes, 
including an abnormal multibudded morphology, an inability to utilize nonfermentable 
carbon sources, heat shock sensitivity, slow growth, temperature sensitivity, and sensitivity 
to caffeine (Loeweth et al., 2000). Also notable was its requirement for normal progression 
through mitosis and meiosis. Some of the phenotypes were suppressed by HDAC inhibitor 
Tricostatin A, demonstrating that the phenotypes are based on defects in acetylation cycle 
(Choy et al., 2001). Yng2p is stabilized by the proteasome inhibitor MG-132, and is likely 
regulated through an ubiquitin-proteasome pathway (Lin et al., 2008).  
4.8 YL-1/*/Vps72 
Human YL-1 is a nuclear protein with an acidic region and a proline-rich region (Horikawa 
et al., 1995), and was identified as a component of Tip60 (NuA4) complex with biochemical 
purification and mass spectrometry. YL-1 is also a part of human counterpart of yeast SWR1 
complex (Cai et al., 2005). Notably, mammalian SRCAP and Drosophila Tip60 complexes are 
associated with histone H2AZ or its fly counterpart H2AvD. These similarities suggest that 
YL-1 may serve as a binding module for histone H2AZ in metazoans, as does Swc2 in yeast 
(Wu et al., 2005).  
In the Kirsten sarcoma virus–transformed NIH3T3 cells highly expressing the exogenous 
human YL-1 protein, the anchorage-independent growth (colony-forming ability in soft agar 
medium) was markedly suppressed. However, in contrast to the suppression of anchorage-
independent growth, the forced expression of YL-1 did not affect the transformed 
phenotypes in adherent culture and tumorigenicity in nude mice. The data suggest that YL-
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1 is involved in the transformation process, and once cells are transformed, additional YL-1 
expression does not play additional role in tumor growth (Horikawa et al., 1995).  
Yeast homolog VPS72 (Vascular Protein Sorting 72, also known as SWC2) is a histone 
variant H2AZ (Htz1p)-binding component of the SWR1 complex, which exchanges Htz1p 
for chromatin-bound histone H2A (Wu et al., 2005). 
4.9 RuvBL1/*/Rvb1(Tip49A) and 
4.10 RuvBL2/*/Rvb2(Tip49B)  
RuvBL1 and RuvBL2 belong to the family of AAA+ ATPases (ATPases Associated with 
various cellular Activities). Ruvbl1 is also called Pontin, NMP238, ECP54, TAP54┙, TIH1 or 
Tip49, while Ruvbl2 is also called Reptin, ECP51, TAP54┙, TIH2 or Tip48. RuvBL1 and 
RuvBL2 bind each other and function as a hexameric helicase (Ikura et al., 2000; Shen et al., 
2000). The names come from their homology with the bacterial RuvB helicase, which is 
involved in DNA recombination and repair. In bacteria, the ruvA-ruvB complex in the 
presence of ATP renatures cruciform structure in supercoiled DNA with palindromic 
sequence, indicating that it may promote strand exchange reactions in homologous 
recombination. RuvAB is a helicase that mediates the Holliday junction migration by 
localized denaturation and reannealing.  
Human RuvBL1 and RuvBL2 are components of multiple multiprotein complexes, INO80, 
SRCAP, URI-1, R2TP and Tip60 (NuA4) complex. RuvBL1 and RuvBL2 were co-
immunoprecipitated or affinity-purified with at least 48 proteins (Grigoletto et al., 2011).  
Human RuvBL1 and RuvBL2 are overexpressed in a variety of cancers inculding colorectal 
(Carlson et al., 2003). Regulation of COX-2 transcription in a colon cancer cell line by 
Pontin52/TIP49a, (Lauscher et al.; 2007; Ki et al., 2007), gastric (Li et al., 2010), bladder 
(Sanchez-Carbayo et al., 2006), mesothelioma (Zhan et al., 2007), non-small cell lung cancer 
(Dehan et al., 2007), as well as in several types of acute (Andersson et al., 2007) or chronic 
leukemias (Haslinger et al., 2004), in multiple myeloma (Zhan et al., 2007) and high-grade 
lymphoma (Nishiu et al., 2002). In ovarian cancer cell lines, microcell-mediated chromosome 
transfer and expression microarray analysis identified nine genes associated with functional 
suppression of tumorogenicity; AIFM2, AKTIP, AXIN2, CASP5, FILIP1L, RBBP8, RGC32, 
RUVBL1 and STAG3. Two SNPs in RUVBL1 were associated with increased risk of serous 
ovarian cancer (Notaridou et al., 2011). The expression of an ATPase-deficient mutant form 
of RuvBL1/TIP49 substantially inhibited ┚-catenin-mediated neoplastic transformation of 
immortalized rat epithelial cells and anchorage-independent growth of human colon cancer 
cells with deregulated ┚-catenin (Feng et al., 2003).  
Disruption of the yeast RuvBL1 (Kanemaki et al., 1999; Lim et al., 2000) or RuvBL2 genes 
(Lim et al., 2000) is lethal.  
4.11 BAF53a (ACTL6a)/Arp4/Arp4  
Human BAF53a (BRG1-associated factor 53a) is also known as ACTL6a (Actin-like 6a). As 
the name implies, the protein  has a 36% identity and 50% similarity with the human beta-
actin. BAF53 is a part of Tip60 (NuA4) complex (Cai et al., 2003, Doyon et al., 2004, 2006). In 
addition, BAF53a is also a part of other multiple multiprotein complexes, including INO80, 
SWI/SNF, and myc-containing nuclear cofactor complex (Park et al., 2002; Sung et al., 2001). 
For SWI/SNF-like protein complex, beta-actin and BAF53 are required for maximal ATPase 
activity of BRG1 and are also required with BRG1 for association of the complex with 
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chromatin/matrix (Zhao et al., 1998). Baf53 protein was also identified as a major binding 
target for HIV Tat protein through affinity chromatography coupled with mass 
spectrometry. The result suggests that Baf53 and Tip60 (NuA4) complex is a major target for 
HIV-1 proviral gene silencing and activation (Gautier et al., 2009).  
In yeast, Arp4/Act3 was identified as a component of NuA4 complex with affinity-
purification followed by mass spectrometry (Galarneau et al., 2000). ARP4 gene is essential 
for growth in yeast (Harata et al., 1994). In temperature-sensitive arp4 mutants, NuA4 
complex disintegrated and lost its activity in restrictive temperature, demonstrating the 
critical role of Arp4 in the NuA4 complex (Galarneau et al., 2000). Upon DNA damage, Arp4 
recognizes and interacts with histone H2A phosphorylated at serine 129. This action recruits 
NuA4 to regions of DNA double-strand breaks where histone H4 acetylation is required for 
DNA double-strand break repair (Bird et al., 2002; Downs et al., 2004).  
4.12 Actin/Act1/Act1  
A major cytoskeletal protein beta-actin is also a subunit of Tip60 (NuA4) complex (Cai et al., 
2003; Doyon et al., 2004, 2006). As in BAF53a, Actin is also a subunit of other multiprotein 
complex. Inhibition of Actin with the Actin monomer sequestering natural product 
Latrunculin B blocks chromatin-dependent ATPase activation of the BAF complex, 
indicating that Actin is a functionally critical component of SWI/SNF complex (Zhao et al., 
1998). As a major cytoskeletal component, beta-actin (Actb) gene is an essential gene, and its 
hypomorph is embryonic lethal in mice (Tondeleir et al., 2009).   
In yeast, in addition to cytoskeletal roles, Act1 is shown to be a component of distinctive 
chromatin remodeling complexes including INO80, SWR and NuA4 (Shen et al., 2000; 
Krogan et al., 2003; Galarneau et al., 2000). Act1 deletion is lethal.  
4.13 MRG15/Eaf3/* 
MRG 15 (Morf-related genes (Mrg) on chromosomes 15 (Mrg15)) belongs to Morf family 
proteins. From cellular senescent study to identify single chromosomes from normal human 
cells that can inhibit growth of immortal human cells, an intronless transcription factor-like 
protein, mortality factor on chromosome 4 (MORF4) was identified. From structural 
homology, other family proteins including MRG15 and MRGX were identified and 
investigated. MRG15 has helix-loop-helix and leucine zipper domains, which are typically 
found in transcriptional regulators, and a chromodomain thought to be involved in protein-
protein interaction in chromatin remodeling factors. MRG15 and -MRGX are expressed 
ubiquitously in all cells and tissues. Currently, MRG proteins, which have pro-growth 
activity, are hypothesized to antagonize growth inhibition activity by Morf4.  
Mrg15 knockout mice are embryonic lethal, and mouse embryonic fibroblasts derived from 
Mrg15 null embryos proliferate poorly, enter senescence rapidly, and have impaired DNA repair 
compared to wild type mice (Tominaga et al., 2005). Mrg15 null embryonic neural stem and 
progenitor cells also have a decreased capacity for proliferation and differentiation (Garcia et al., 
2007). Expression of the cyclin-dependent kinase inhibitor p21 is specifically up-regulated in 
Mrg15 deficient neural stem/progenitor cells (NSCs). Mrg15 deficient NSCs exhibit severe 
defects in DNA damage response following ionizing radiation (Chen et al., 2011). 
So far, cancer association of Mrg15 has been poorly shown. No alterations or mutations were 
identified for MRG15/MORF4L1 in unclassified FA patients and Breast Cancer (BrCa) 
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familial cases. No significant associations between common MORF4L1 variants and BrCa 
risk for BRCA1 or BRCA2 mutation carriers were identified (Martrat et al., 2011).  
Yeast Eaf3 is a shared component of the NuA4 complex and Rpd3 histone deacetylase 
complex. The loss of Eaf3 greatly alters the genomic profile of histone acetylation (Reid et 
al., 2004).  
4.14 GAS41/Yaf9/Yaf9  
GAS41 (Glioma Amplified Sequence 41) is a nuclear protein containing a C-terminal alpha-
acidic activation domain and an N-terminal YEATS domain (Fischer et al., 1997). The 
YEATS domain family of proteins is well conserved from yeast to human, and functions as 
transcriptional regulators as a part of multiprotein complexes. GAS41 is associated with 
TFIIF via its YEATS domain. GAS41 is also a subunit of the human TIP60 and SCRAP 
complexes (Doyon et al., 2004; Cai et al., 2005). In addition, GAS41 physically interacts with 
transforming acidic coiled-coil 1(TACC1) protein, microtubule-associated colonic and 
hepatic tumor overexpressed (ch-TOG) protein and nuclear matrix (NuMA) protein 
(Lauffart et al., 2002; Harborth et al., 2000).  
Yeast homolog Yaf9 encodes a protein of 226 residues, containing an N-terminal YEATS 
domain and a C-terminal predicted coiled-coil sequence (Le Masson et al., 2003). Deletion of 
Yaf9 shows pleiotropic effect, including sensitivity to a variety of drugs such as cadmium, 
cecium chrolide, cycloheximide, and microtubule inhibitor benomyl. The phenotype is 
associated with a change in transcriptome. The transcriptomic change can be suppressed by 
Bdf1 multicopy expression, suggesting functional overlapping between these two 
components (Bianchi et al., 2004). Since human Brd8 (Bdf1) was isolated from a screen that 
influenced sensitivity to microtubule inhibitors, it is tempting to speculate that Brd8-GAS41 
(Bdf1-yaf9) may be an interface module to genes involved in sensitivity to microtubule 
inhibitors.  
4.15 */Eaf5/* 
Yeast Eaf5 (Esa1p-associated factor 5) is a component of yeast NuA4 complex (Nourani et 
al., 2001). Its direct human counterpart is unclear. Eaf5 protein forms subcomplex with Eaf7, 
and Eaf5 interacts with NuA4 complex (Mitchell et al., 2008). Eaf5 deletion strain is viable, 
and shows resistance to chemicals such as acetic acid and lactic acid (Kawahata et al., 2006).   
Deletion strains of eaf5 and eaf7 display similarity in microarray transcriptional profiles 
(Krogan et al., 2006). 
4.16 MRGBP/Eaf7/* 
MRGBP (MRG Binding Protein) was identified as a NuA4 component with biochemical 
purification (Cai et al., 2003). MRGBP is also a component of the human INO80 complex (Jin 
et al., 2005). Crystal structure determination of the MRG domain indicated that MRGBP has 
structural similarity to DNA binding domains of the tyrosine site-specific recombinases 
XerD, lambda integrase, and Cre (Bowman et al., 2006).  
In human colon cancer, MRGBP was upregulated in the majority of the cancers. Inhibition of 
MRGBP with shRNA in vitro resulted in an inhibition of cell growth (Yamaguchi et al., 
2010). High levels of MRGBP expression were observed more frequently in human colonic 
carcinomas (45%) than adenomas (5%), linking its role to malignant properties of colorectal 
tumors (Yamaguchi et al., 2011).  
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Fig. 1. Tip60 (NuA4) complex is assembled by combining subcomplexes and subunits. Each 
subunit of Tip60 (NuA4) complex is linked to different biological events, presumably 
because each subunit represents an interface to the proteins involved in the particular 
events. Inhibition of a subunit results in different phenotypes, which may provide 
intervention opportunities for cancer prevention and/or therapeutic purpose. 
Abbreviations: PDAC (Pancreatic Ductal Adeno Carcinoma); ES cell (Embryonic Stem cell); 
NSCLC (Non Small Cell Lung Cancer); HNSCC (Head and Neck Small Cell Carcinoma).  
4.17 hEaf6/Eaf6/* 
Human Eaf6 was isolated as a component of Tip60 (NuA4) complex (Doyon et al., 2004). 
hEaf6 is also a component of HBO and/or MOZ/MORF HAT complex (Ullah et al., 2008; 
Saksouk et al., 2009).  
5. Relevance to colon cancer  
Among multiple subunits, Brd8, MRGBP, RuvBL1 and RuvBL2 show particularly strong 
connections to colon cancer. These subunits are overexpressed in colon cancer (Yamada and 
Rao, 2009; Yamaguchi et al.,2010, 2011; Carlson et al., 2003; Lauscher et al., 2007; Graudens et 
al., 2006; Ki et al., 2007). Brd8 plays a role in survival and/or drug resistance of cultured 
colon cancer cells. MRGBP also plays a role in survival of cultured colon cancer cells. 
RuvBL1 is an important cofactor in beta-catenin/TCF gene regulation, and expression of its 
dominant-negative form inhibited ┚-catenin-mediated neoplastic transformation of 
www.intechopen.com
 
Colorectal Cancer Biology – From Genes to Tumor 
 
230 
immortalized rat epithelial cells and anchorage-independent growth of human colon cancer 
cells with deregulated ┚-catenin (Feng et al., 2003). 
In addition, DMAP1 associated proteins (DNMT1,3A and 3B) were progressively 
upregulated in colorectal adenoma-carcinoma sequence (Schmidt et al., 2007). DNMT1 may 
play a role in colon cancer progression directly or indirectly.  
6. Subunit-specific targeting strategy  
As in above, deregulations in subunits of human Tip60 (NuA4) complex are common in 
various cancers, and the complex is gaining attention as a potential target for cancer 
therapy. However, concerns for targeting whole Tip60 (NuA4) complex are raised because 
the complex plays essential roles for cellular survival and targeting the core components of 
the complex would impair the essential functions, which may lead to general toxicity to both 
normal and cancer cells. Although many successful drugs in existence do target essential 
and ubiquitous cellular components (e.g. Taxol for microtubule, Velcade for proteasome), 
the concern needs to be addressed.  
As a rebuttal, targeting of each component has been proposed. Although the Tip60 (NuA4) 
complex is thought to function as a complex, targeting each subunit does not necessarily 
show the same biological effect and phenotype empirically, suggesting unique roles of each 
subunit. This fact may be exploited for developing therapeutic strategy. Further 
investigation of the unique roles of each subunit would allow us to develop subunit-specific 
targeting strategies for therapeutic purpose.   
Extrapolating from yeast and mice results, the following subunits of Tip60 (NuA4) complex 
are essential for cellular survival; TRRAP, p400, EPC1, Tip60, DMAP1, RuvBL1, RuvBL2, 
BAF53a and Actin. Inhibiting these subunits may require caution. Components whose 
inhibition may not directly or immediately kill cells are; Brd8, ING3, YL-1, MRG15, GAS41, 
MRGBP and hEaf6. Inhibition of these components may prove valuable as an adjuvant 
approach to improve other therapies such as chemo- and radio-therapies.  
In some subunits and associating factors (Brd8, MRGBP, DNMT1), overexpression is 
correlated to stage advancement of colon cancer, thus drug-mediated inhibition seems 
intuitively appropriate. GAS41 and Brd8 may have a more prominent effect on cellular 
sensitivity to anti-microtubule drugs. It is possible that chemoresistance of colon cancer is at 
least in part provided by deregulation of these subunits, and drug-mediated inhibition of 
these subunits results in enhancement of the effect of these drugs.   
7. Conclusion  
Accumulating evidence supports that the Tip60 (NuA4) complex plays a role in various 
cancers including that in colon, and possibly in drug sensitivity/resistance of cells. Targeting 
the components may prove successful in preventing cancer and/or in killing or 
chemosensitizing cancer cells. Since the major hindrance to a colon cancer cure is its 
chemoresistance, chemosensitizing through modulation of the Tip60 (NuA4) complex 
component seems to be a novel and attractive strategy. However, thus far validation of Tip60 
(NuA4) complex, or the subunit(s), as a therapeutic target is yet to be performed. Continuing 
investigation is required to translate current knowledge to clinical or translational studies. 
Strategies for targeting (e.g. siRNA, small molecule) should be explored.  
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